- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05185128
Neural Basis of Social Cognition Deficits
Neural Basis of Social Cognition Deficits in Youth With Autism and Schizophrenia
Study Overview
Status
Intervention / Treatment
Detailed Description
Difficulties in reciprocal social interaction are hallmark features of several neuropsychiatric disorders, most notably autism spectrum disorder (ASD) and schizophrenia spectrum disorder (SSD). Recent behavioral studies of adults with SSD and ASD have highlighted not only the similarities but also some divergent patterns of social impairments in the two disorders - with ASD characterized by lower social motivation, poorer social reciprocity, and undermentalizing, and SSD characterized by greater reciprocity but poor expressiveness. Given the public health significance of social disability and social isolation, it is crucial to explore the neurobiological mechanisms underlying these social skill deficits across both groups, as well as to understand how these relate to real-world behaviors. Although antipsychotics have been shown to be effective in reducing positive symptoms in SSD, they are not effective in addressing the devastating social disability associated with the disorder, which contributes to chronic functional impairment. It is thus imperative to identify behavioral interventions for children and adolescents that have already shown promise in other clinical groups such as ASD. By enhancing our understanding of the neurobiological underpinnings of social impairments in adolescent-onset SSD and how they compare to those observed in ASD, we will be able to refine treatment targets and better predict outcomes for each group. To this effect, the proposed study will examine biomarkers that are likely related to positive outcomes from targeted social skills intervention in adolescents with SSD and ASD. Building upon an established evidence-based treatment - the Program for the Education and Enrichment of Relational Skills (PEERS), we will collect resting state functional imaging (rs-fcMRI), task-paradigm functional BOLD activation (fMRI), and magnetic resonance spectroscopy (MRS) before and after 30 SSD and 30 ASD adolescents, 12-18 years of age, undergo the 16-week evidence-based PEERS behavioral intervention. These data will then be compared to a matched sample of 30 typically developing (TD) adolescents who are not enrolled in the PEERS program but will undergo two MRI scans 16-weeks apart. The overarching goal of the study will be to create a novel multimodal neuroimaging design to examine the neural underpinning of social difficulties in SSD and ASD, explore neuroplasticity in both groups in response to a brief targeted social-skills intervention, and predict treatment response and its contribution to long-term maintenance of skills after treatment completion.
The following are the study's specific aims:
Aim 1: Assess treatment related changes in 'social brain' regions following evidence-based social skills training in ASD and SSD group, compared to neural patterns observed in TD adolescents.
Hypothesis 1a: rs-fcMRI indices within social brain networks will look more improved (similar to TD adolescents) post-treatment compared to pre-treatment for the both ASD and SSD groups (e.g., greater connectivity in social brain networks in ASD group, lower connectivity of extraneous regions in SSD group).
Hypothesis 1b: fMRI brain activation in social brain regions in response to the social task-paradigm will look more improved (similar to TD adolescents) post-treatment compared to pre-treatment for both ASD and SSD group (e.g., greater activation in social brain networks in ASD group, lower activation of extraneous regions in SSD group). Hypothesis 1c: There will be significant improvement (similar to TD adolescents) in MRS indices of GABA (inhibitory) and glutamate (excitatory) neurometabolite concentrations within social brain networks in ASD and SSD post- treatment compared to pre-treatment (e.g., lower glutamate/higher GABA in social brain regions in ASD group, higher glutamate/higher GABA in social brain regions in SSD group).
Aim 2: To test whether pre- and post-treatment neural changes are meaningfully related to behavioral measures of treatment outcome.
Hypothesis 2: Neural responses post-intervention will correlate with gains in social motivation and reciprocity behavioral outcomes measures in the ASD group, and gains in social expressivity outcome measures in the SSD group.
Exploratory Aim 3: Given that both ASD and SSD are characterized as spectrum disorders of varying severity, heterogeneous etiologies, and comorbidities, we aim to explore how individual differences in patterns of brain connectivity and activation might predict treatment response and treatment maintenance dimensionally in addition to the category-based diagnostic systems proposed above. Given the exploratory nature of the proposed aim, specific hypotheses are not projected regarding the precise changes in neural activity on an individual basis. However, accomplishing this goal will us understand underlying neural mechanisms of treatment-related change across groups, and serve to better target interventions to address the heterogeneity of social cognition deficits observed in both ASD and SSD.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Aarti Nair, PhD
- Phone Number: 9095588707
- Email: anair@llu.edu
Study Locations
-
-
California
-
Loma Linda, California, United States, 92354
- Recruiting
- Loma Linda U
-
Contact:
- Aarti Nair, Ph.D
- Phone Number: 88707 909-558-8707
- Email: anair@llu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Participants in this study will be 30 ASD adolescents and 30 demographically matched adolescents with SSD who undergo the PEERS social skills training program. Participants will be between the ages of 12-18 years, and mostly male reflecting the higher prevalence in the population of ASD, and to a lesser extent, SSD. The ASD adolescents will be recruited through the Loma Linda University Behavioral Health Institute (LLU BHI), LLU Behavior Medicine Center (BMC), and LLU Department of Psychology Child and Family Center (CFC). The SSD adolescents will be recruited from the BMC inpatient, partial hospitalization, intensive outpatient, and standard outpatient programs for youth with psychosis. Thirty demographically comparable typically developing (TD) controls will be recruited through community samples, and in compliance with the LLU Institutional Review Board (IRB) standards. Before enrolling in the proposed MRI studies, prospective ASD participants will undergo testing with experienced assessors. Clinical diagnosis will be confirmed using both the Autism Diagnostic Interview- Revised, and the Autism Diagnostic Observation Schedule, 2nd edition. SSD participants will be screened using the Structured Clinical Interview for DSM-IV (SCID) Axis I diagnoses, with additional modules for assessment of childhood disorders. SSD participants must meet criteria for schizophrenia, schizophreniform, schizoaffective disorder, or unspecified schizophrenia spectrum and other psychotic disorder. All study participants will have verbal IQ as well as Full Scale IQ of 70 or higher on the Wechsler Abbreviated Scale of Intelligence (WASI-II) to ensure they will have the language and cognitive ability to participate in an MRI scan.
Exclusion Criteria:
Exclusion criteria will include history of significant medical/neurologic conditions that would affect neuroimaging interpretation (e.g., epilepsy, tumor), and any psychiatric history for TD controls. Participants with any MRI contraindications (e.g., history of metal fragment injury or metal implants, current orthodontic braces or nonremovable retainers) will also be excluded in compliance with scanner safety standards.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control arm
Typically developing control participants will undergo cognitive assessments and MRI imaging 16 weeks apart with no intervention in between.
|
|
|
Experimental: Patient arm
Both ASD and SSD participants will undergo cognitive assessments and MRI imaging pre- and post- the 16-week PEERS social skills intervention.
|
The PEERS treatment program consists of 90-minute sessions, delivered once a week over the course of 16- weeks.
Parents and children/adolescents attend separate concurrent sessions that instruct them on key elements about making and keeping friends.
Among others, this parent-assisted, social skills intervention provides explicit instruction to target verbal and nonverbal communication skills, appropriate use of humor and resolving peer conflict, as well as expanding and developing friendship networks38.
The candidate, Dr. Nair, has been trained on the PEERS social skills intervention extensively for the past five years, and is a certified provider for the adolescent program.
The PEERS program will be provided by Dr. Nair's research team (consisting of Dr. Nair, lab co-ordinators, and clinical psychology doctoral students) through the LLU Department of Psychology.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Awareness of Social Inference Test (TASIT)
Time Frame: Change between baseline and final visit at week 16
|
This is a Theory of Mind (ToM) measure containing 16 videotaped scenes.
After each scene, subjects respond to questions about the characters' intentions, beliefs about the situation, and emotional state.
|
Change between baseline and final visit at week 16
|
|
The Social Attribution Task - Multiple Choice (SAT-MC, SAT-MC-II)
Time Frame: Change between baseline and final visit at week 16
|
his test uses a 64- second video of geometric shapes set in motion to portray themes of social relatedness and intentions.
Considered a test of "Theory of Mind," the SAT-MC and its alternative form SAT-MC-II assesses implicit social attribution formation while reducing verbal and basic cognitive demands.
|
Change between baseline and final visit at week 16
|
|
The computerized Penn Emotion Identification Task (PennCNB)
Time Frame: Change between baseline and final visit at week 16
|
The PennCNB Emotion Identification Test (EMI) measures the ability to correctly identify facial expressions of emotion.
Participants are shown 40 faces one at a time on the computer, and must identify the emotion expressed by the actors face from multiple choice options provided.
|
Change between baseline and final visit at week 16
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional MRI
Time Frame: Change between baseline and final visit at week 16
|
rs-fcMRI indices within social brain networks will look more improved (similar to TD adolescents) post-treatment compared to pre-treatment for the both ASD and SSD groups (e.g., greater connectivity in social brain networks in ASD group, lower connectivity of extraneous regions in SSD group).
Rate of connectivity ranges from -3 low to +3 high connectivity.
|
Change between baseline and final visit at week 16
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Aarti Nair, PhD, Loma Linda University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5200189
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
University of California, Los AngelesUniversity of WashingtonRecruitingAutism Spectrum Disorder (ASD)United States
Clinical Trials on PEERS social skills intervention
-
Seoul National University Bundang HospitalSeoul St. Mary's Hospital; Kyung Hee University HospitalActive, not recruiting
-
Southwest Autism Research & Resource CenterMayo Clinic; Arizona State UniversityCompletedAutism Spectrum DisorderUnited States
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedAutistic Disorder | AutismUnited States
-
Seoul National University HospitalCompletedAutism Spectrum Disorder | Autism
-
Medical University of South CarolinaEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
Milton S. Hershey Medical CenterCompletedAutism Spectrum DisordersUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)Completed
-
University of Sao PauloUnknownSchizophrenia and Disorders With Psychotic FeaturesBrazil